The review found that, based on low quality evidence, available treatments for varicose veins appeared safe and surgery appeared effective long term. Less invasive treatments caused less periprocedural disability and pain but their effectiveness was supported only by short-term studies. These conclusions require some caution in interpretation due to large differences between the included studies.
Study selection
Randomised controlled trials (RCTs) and cohort studies that compared treatments for varicose veins (surgery, sclerotherapy, percutaneous endovenous thermal interventions or conservative management with compression stockings) were eligible for inclusion. Studies were required to report varicose vein recurrence, patient satisfaction, aesthetics, return to work, pain and/or procedure-related complications (wound-related and/or systemic).
Participants in the included studies had a mean age of 49 years and 70% were women. Participant characteristics, interventions, comparisons and outcome measures varied widely between studies. In some studies sclerotherapy was restricted to participants with specific clinical characteristics. Clinical outcomes were measured by clinical encounter or record review. Patient satisfaction, pain and quality of life were measured by questionnaires. Many studies reported surrogate outcomes (such as ultrasound measurements) rather than clinical outcomes. Mean follow-up was 31 months (range three months to 10 years). Two reviewers independently selected the studies. Disagreements were resolved by consensus or arbitration by a third reviewer.
Assessment of study quality
Items for validity assessment included randomisation, allocation concealment, blinding of outcome assessment, followup duration, losses to follow-up, baseline comparability of groups, adjustment for confounding, funding source and outcome ascertainment. The overall quality of evidence was graded from high to very low using the GRADE framework.
Two reviewers independently assessed study validity. Disagreements were resolved by consensus or arbitration by a third reviewer.
Data extraction
All data were dichotomous. Relative risks (RRs) with 95% confidence intervals (CIs) were extracted or calculated.
Two reviewers independently extracted data. Disagreements were resolved by consensus or arbitration by a third reviewer.
Methods of synthesis
Studies were combined to calculate pooled relative risks with 95% CIs using a random-effects model. Heterogeneity was assessed with Ι². Subgroup, sensitivity and meta-regression analyses were planned or undertaken to examine the effects of study quality, participant characteristics (such as gender), disease severity, follow-up duration and exclusion 
Results of the review
Thirty-nine studies were included (8,285 participants, range 28 to 733): 29 RCTs, one quasi-RCT and nine observational studies. The overall quality of evidence was rated as low to very low. Five RCTs were rated as having adequate allocation concealment (for four of these the only descriptor in the review was sealed envelopes). Two RCTs used blinded outcome assessment. Common limitations of observational studies included possible baseline differences, unblinded outcome assessment and losses to follow-up that were high or unreported and unequal between study arms. Outcome ascertainment was adequate in all studies. Most studies failed to report funding source. Seven were commercially funded.
Surgery was associated with a non-statistically significant reduced risk of varicosity recurrence compared to liquid sclerotherapy (RR 0.56, 95% CI 0.29 to 1.06; 10 studies). This difference was statistically significant when analysis was restricted to studies with at least two years' follow-up (RR 0.45, 95% CI 0.22 to 0.93; seven studies). Surgery was associated with a non-statistically significant reduced risk of varicosity recurrence when compared with all endoluminal therapies (laser, radiofrequency and foam) (RR 0.63, 95% CI 0.37 to 1.07; 16 studies). All three analyses had very high heterogeneity (Ι²=90% to 93%).
Several studies reported that endoluminal therapies were associated with less procedure-related disability and pain than surgery. In general all treatments were well tolerated, although data on deep vein thrombosis and pulmonary embolism were sparse and poorly reported.
The review also reported comparisons of non-surgical therapies and the results of other subgroup analyses.
Authors' conclusions
Based on low-quality evidence, available treatments for varicose veins appeared safe and surgery appeared effective long term. Less invasive treatments caused less periprocedural disability and pain, but their effectiveness was supported only by short-term studies.
CRD commentary
The objectives and inclusion criteria of the review were clear. Relevant sources were searched for studies in any language. It was unclear whether the search was restricted by publication status and potential for publication bias was not discussed. Steps were taken to minimise risks of reviewer bias and error by having more than one reviewer independently select studies, undertake validity assessment and extract data.
